Search Results
Found 1 results
510(k) Data Aggregation
(174 days)
The Disposable Medical Safety Hypodermic Needle is intended for use in the aspiration and injection of fluids for medical purposes. The Disposable Medical Safety Hypodermic Needle is compatible for use with standard luer slip and luer lock syringes.
Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle-stick.
The Disposable Medical Safety Hypodermic Needle is composed of a needle hub, a needle tube, a needle cap and a sharp injury protection feature. The sharp injury protection feature is simultaneously activated when manually pressed over the needle after use and prior to disposal to minimize the possibility of sharps injury. The sharp injury protection feature is activated with one-hand operation by pressing the sharp injury protection feature either with the finger or thumb, or by surface activation. The locking mechanism is positioned within the center and proximal end of the sharp injury protection feature. The hinge feature(sharp injury protection feature) allows the medical practitioner the flexibility to adjust the sharp injury protection feature to its desired position for use.
This document describes the FDA's 510(k) clearance for the Hantech Medical Device Co., Ltd.'s Disposable Medical Safety Hypodermic Needle. The clearance is based on the device being substantially equivalent to a legally marketed predicate device (TK Safety Needle, K191644).
Here's the breakdown of the acceptance criteria and the study that proves the device meets them:
1. Table of Acceptance Criteria and Reported Device Performance
The device's performance is demonstrated through adherence to various international ISO standards, indicating it meets the acceptance criteria defined within those standards. The document doesn't provide specific numerical targets for "acceptance criteria" but rather states conformity to the clauses of these standards, which implicitly define the acceptance thresholds.
| Acceptance Criteria (Standard & Clause) | Reported Device Performance (Conformity) | Comments |
|---|---|---|
| Biocompatibility: | ||
| Cytotoxicity (ISO 10993-5: 2009) | Performed in accordance with ISO 10993-1:2018 (body contact: "External communication device - Blood path indirect", < 24 hours) | Device evaluated according to recommended tests for biocompatibility. |
| Skin sensitization (ISO 10993-10: 2010) | Performed in accordance with ISO 10993-1:2018 (body contact: "External communication device - Blood path indirect", < 24 hours) | |
| Hemolysis (ISO 10993-4: 2017) | Performed in accordance with ISO 10993-1:2018 (body contact: "External communication device - Blood path indirect", < 24 hours) | |
| Intradermal reactivity (ISO 10993-10: 2010) | Performed in accordance with ISO 10993-1:2018 (body contact: "External communication device - Blood path indirect", < 24 hours) | |
| Acute systemic toxicity (ISO 10993-11: 2017) | Performed in accordance with ISO 10993-1:2018 (body contact: "External communication device - Blood path indirect", < 24 hours) | |
| Pyrogenicity (ISO 10993-11: 2017) | Performed in accordance with ISO 10993-1:2018 (body contact: "External communication device - Blood path indirect", < 24 hours) | |
| Sterilization & Shelf Life: | ||
| Sterilization (ISO 11135:2014) | Validated to ISO 11135, routine control and monitoring parameters determined | Demonstrates effective sterilization. |
| Ethylene oxide residuals (ISO 10993-7:2008) | Conforms | Ensures safe residual levels of sterilant. |
| Packaging materials (ISO 11607-1: 2019) | Performed | Ensures packaging maintains sterility. |
| Packaging validation (ISO 11607-2: 2019) | Performed | Ensures packaging integrity. |
| Accelerated Aging (ASTM F1980-16) | Used for shelf life determination | Supports shelf life claims. |
| Performance Testing (ISO 7864: 2016 - Sterile Hypodermic Needles): | ||
| Cleanliness (Clause 4.3) | Conforms | Ensures product is free from contaminants. |
| Limits for acidity or alkalinity (Clause 4.4) | Conforms | Ensures biocompatibility and stability. |
| Limits for extractable metals (Clause 4.5) | Conforms | Ensures patient safety. |
| Tubular needle designation (Clause 4.6) | Conforms | Ensures correct labeling and identification. |
| Colour coding (Clause 4.7) | Conforms | Follows industry standards for easy identification. |
| Needle hub (Clause 4.8, ISO 80369-7 & ISO 6009) | Conforms | Ensures proper connection and compatibility. |
| Needle cap (Clause 4.9) | Conforms | Ensures protection of the needle. |
| Needle tube (Tolerance on length, Freedom from defects, Lubricant) (Clause 4.10) | Conforms | Ensures proper function and ease of use. |
| Needle Point (Clause 4.11) | Conforms | Ensures sharpness and smooth penetration. |
| Bond between Tube and Hub (Clause 4.12) | Conforms | Ensures structural integrity. |
| Patency of Lumen (Clause 4.13) | Conforms | Ensures unobstructed fluid flow. |
| Performance Testing (ISO 9626:2016 - Stainless steel needle tubing): | ||
| Surface finish and visual appearance (Clause 5.2) | Conforms | Ensures quality and usability. |
| Cleanliness (Clause 5.3) | Conforms | |
| Limits for acidity and alkalinity (Clause 5.4) | Conforms | |
| Size designation (Clause 5.5) | Conforms | |
| Dimensions (Clause 5.6) | Conforms | |
| Stiffness (Clause 5.8) | Conforms | Ensures needle rigidity. |
| Resistance to breakage (Clause 5.9) | Conforms | Ensures needle integrity during use. |
| Resistance to corrosion (Clause 5.10) | Conforms | Ensures material durability and patient safety. |
| Performance Testing (ISO 80369-7:2016 - Luer connectors): | ||
| Dimensional requirements for luer connectors (Clause 5) | Conforms (2021 version mentioned implies adherence to latest standards) | Ensures universal compatibility. |
| Fluid leakage (Positive pressure liquid leakage) (Clause 6.1.3) | Conforms (2021 version mentioned implies adherence to latest standards) | Prevents leakage during aspiration/injection. |
| Sub-atmospheric pressure air leakage (Clause 6.2) | Conforms (2021 version mentioned implies adherence to latest standards) | Prevents air aspiration. |
| Stress cracking (Clause 6.3) | Conforms (2021 version mentioned implies adherence to latest standards) | Ensures material resilience. |
| Resistance to separation from axial load (Clause 6.4) | Conforms (2021 version mentioned implies adherence to latest standards) | Ensures secure connection. |
| Resistance to separation from unscrewing (Clause 6.5) | Conforms (2021 version mentioned implies adherence to latest standards) | Ensures secure connection. |
| Resistance to overriding (Clause 6.6) | Conforms (2021 version mentioned implies adherence to latest standards) | Ensures proper connection. |
| Performance Testing (ISO 23908 & Sharps Injury Prevention Guidance): | Specific to the safety feature. | |
| Activation torque | Performed | Ensures proper function of safety mechanism. |
| Protection features separating force | Performed | Ensures integrity of safety mechanism. |
| Resistance to breakage | Performed | Ensures durability of safety mechanism. |
| Simulated Clinical Use Testing Report | Performed | Simulates real-world use to confirm safety and effectiveness. |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the specific sample sizes used for each test. Instead, it indicates that testing was performed according to various ISO standards. These standards typically define appropriate sample sizes and methodologies for testing.
The data provenance is from China, as the submitting company, Hantech Medical Device Co., Ltd., is located in Ningbo, People's Republic of China. The studies are pre-market studies conducted to support the 510(k) submission, indicating a controlled, laboratory or simulated environment, rather than prospective clinical trials in humans.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts
This information is not provided in the document. The studies primarily involve objective performance testing against established international standards rather than expert-driven ground truth establishment for a diagnostic or AI device.
4. Adjudication Method for the Test Set
This information is not applicable as the studies described are for the physical and functional performance of a hypodermic needle, not for diagnostic interpretation or a device requiring expert adjudication of results.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
No, an MRMC comparative effectiveness study was not done. This type of study is typically conducted for diagnostic or imaging devices to assess the impact of AI on human reader performance. The device in question is a medical needle, not an AI or diagnostic device.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done
No, a standalone performance evaluation in the context of an algorithm or AI was not done. The device is a physical medical instrument.
7. The Type of Ground Truth Used
For the performance testing, the "ground truth" is defined by the specifications and requirements set forth in the referenced ISO and ASTM standards. These standards prescribe acceptable ranges, physical properties, and functional outcomes. For example, the cleanliness clause of ISO 7864 dictates the "ground truth" for acceptable levels of contamination.
8. The Sample Size for the Training Set
This information is not applicable as the device is a physical medical product and not an AI/machine learning model that would require a "training set."
9. How the Ground Truth for the Training Set Was Established
This information is not applicable for the same reason as above; there is no training set for this type of device.
Ask a specific question about this device
Page 1 of 1